Potent and highly selective CDK9 inhibitor for treatment of hematologic malignancies
To evade cell cycle controls, malignant cells rely upon rapid expression of select proteins to mitigate pro-apoptotic signals resulting from damage caused by both cancer treatments and unchecked over-proliferation. Cyclin-dependent ...
Dec 29, 2023
0
20